How many employees does SSCP Blink Bidco Limited have?

SSCP Blink Bidco Limited reported an average of 1 employee in the year to 31 Dec 2025.

Company No. 09549235 · Incorporated 19 Apr 2015

SSCP Blink Bidco Limited

Q: Is SSCP Blink Bidco Limited profitable?

No — SSCP Blink Bidco Limited reported a loss of £6.5m in the year to 31 Dec 2025.

Registered name: SSCP BLINK BIDCO LIMITED

SSCP Blink Bidco Limited made a £6.5m loss in the year to 31 Dec 2025 (revenue not disclosed).

SSCP Blink Bidco Limited reported a loss of £6.5m in the year to 31 Dec 2025; its revenue was not disclosed. It had 1 employee. The company is classified under “wholesale of pharmaceutical goods” and is based in Macclesfield; we hold 4 years of its filed accounts.

Profit onlySection G · Wholesale and retail trade; repair of motor vehiclesSIC 46460Wholesale of pharmaceutical goods

Status: Active
Location: Macclesfield, North West
Age: 11 yrs · since 2015
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The Company is a wholly owned subsidiary undertaking of Vision Ophthalmology Group GmBH, a Company registered in Germany. As at the year end the Company's ultimate parent undertaking, Addlife AB, incl”

Latest accounts · year to 31 Dec 2025

Key figures

Small team

Revenue

—

Not disclosed in filing

Profit

−£6.5m

Growth —

Profit margin

—

Employees

Change 0%

Profit / employee

−£6.5m

Profitable streak

0yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	No P&L	No P&L	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—	—	—
Operating profit	—	—	−£12k	−£12k
Profit before tax	—	—	−£2.6m	−£6.5m
Profit after tax	—	—	−£2.6m	−£6.5m
Profit (best available)	—	—	−£2.6m	−£6.5m
Employees (average)	2	2	1	1
Ratios
Profit margin	—	—	—	—
Profit per employee	—	—	−£2.6m	−£6.5m
Growth (year on year)
Headcount growth	—	0%	▼50%	0%
Balance sheet — indirect signals, not revenue
Net assets	−£7.4m	−£11m	−£13.7m	−£20.1m
Fixed assets	£11m	£7.4m	£5.5m	£100
Deferred income	£11.4k	£12.7k	£14.7k	£18.2k
Source	Accounts · bulk data Aug 2024	Accounts · bulk data Aug 2024	FullAccounts · bulk data May 2025	FullAccounts · bulk data Aug 2026

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: −£6.5m; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now −£20.1m
Cash at bank: —; Now —
Headcount: 0%; Now 1
Deferred income: ▲24%; Now £18.2k
Fixed assets: ▼100%; Now £100

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Subsidiaries (1)

Vision Pharmaceuticals LtdRev. £3.7m · Profit −£537k

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit −£6.5m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.